within Pharmacolibrary.Drugs.ATC.J;

model J01DH51
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.16666666666666666,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Imipenem and cilastatin is a combination antibiotic approved for treatment of serious bacterial infections, particularly hospital-acquired or complicated infections caused by susceptible organisms. Imipenem is a broad-spectrum beta-lactam carbapenem antibiotic, while cilastatin is a dehydropeptidase inhibitor added to prevent the renal breakdown of imipenem and prolong its antibacterial activity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects after intravenous administration.</p><h4>References</h4><ol><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2007). Comparative review of the carbapenems. <i>Drugs</i> 67(7) 1027–1052. DOI:<a href=&quot;https://doi.org/10.2165/00003495-200767070-00006&quot;>10.2165/00003495-200767070-00006</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/17488146/&quot;>https://pubmed.ncbi.nlm.nih.gov/17488146</a></p></li><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2019). Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. <i>Drugs</i> 79(3) 271–289. DOI:<a href=&quot;https://doi.org/10.1007/s40265-019-1055-2&quot;>10.1007/s40265-019-1055-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30712199/&quot;>https://pubmed.ncbi.nlm.nih.gov/30712199</a></p></li><li><p>Sagan, O, et al., &amp; Srinivasan, S (2020). Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis. <i>Antimicrobial agents and chemotherapy</i> 64(3) –. DOI:<a href=&quot;https://doi.org/10.1128/AAC.01506-19&quot;>10.1128/AAC.01506-19</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31843995/&quot;>https://pubmed.ncbi.nlm.nih.gov/31843995</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DH51;
